
An 'Acquisition Engine' for Longevity





Element Longevity is built to navigate this future using science and technology.
A Longevity Crisis Meets a Shift in Awareness
The Burden
The Signal
The Gap
The Market Gap: Validated Inefficiency
Transient Probiotics
Missing Keystones
Most probiotics are tourists, not residents. They fail to engraft or restore the 'Keystone Species' (like Bifido) essential for long-term gut resilience.
Shift to human-native strains selected for permanent colonization.
Generic Formulas
The One-Size Flaw
Universal supplements ignore biological individuality. 95% of adults fail to get the specific medical-grade nutrition needed to fuel their unique microbiome.
Demand for precision medical nutrition targeting specific metabolic outcomes.
The Adherence Gap
Zero Feedback Loop
Health protocols fail because they are boring and invisible. Users quit because they lack immediate incentives or tangible rewards for daily compliance.
Gamified adherence with real-world rewards for biological wins.
Data Waste
Fragmented Signals
Wearable data, lab results, and symptom logs remain trapped in silos. Consumers are drowning in data but starving for a single, actionable metric.
A Unified Longevity Score that synthesizes all inputs into one number.
Where Longevity Becomes Actionable
Bifidobacterium adolescentis and Bifidobacterium longum are naturally abundant in healthy aging populations. They regulate carbohydrate metabolism, immune signaling, and gut barrier function. They decline with age, diet, and antibiotic use — and 99% of probiotic brands don't include them in any meaningful form.
Human-Native Strains
Selected using in vivo methods for persistence at significantly higher abundance than conventional probiotics. They colonize — not pass through.
Clinical Differentiator
Strains support gut barrier integrity and butyrate production — the mechanisms behind energy, immunity, and inflammation control. Measurable biology, not marketing.
Proprietary IP & Pipeline
Exclusive formulation relationships with leading biotech partners. R&D pipeline includes 4+ new Bifidobacterium strain SKUs across targeted health categories.
Element Longevity
Multi-strain synbiotic · High-efficacy restoration · Flagship
Holy Cow!
Targeted lactose relief · Bifido + precision prebiotic
Human Strain
Single-strain purity · B. adolescentis focus
R3VY
Metabolic performance · Gut-energy axis · Athletic
From a Single Entry Point to a Longevity Platform
Engage
Early biological signals → motivation. Low CAC retail scale via Amazon & TikTok.




Understand
Intake, lifestyle data, emerging patterns. Lead Gen & Proprietary Data.

Refine
Increasing precision over time. Upsell to deeper precision (High LTV).
Consistent Outcomes Across Early Cohorts
Element Longevity
Holy Cow!
Human Strain
Methodology: Participants completed a baseline intake and stool test, followed a personalized Element One protocol for 90 days.
High-Signal Biological Use Cases
Signal identification
Monitor consumer search, social, and symptom data to identify unmet biological needs before they become crowded categories.
Formula assignment
Our proprietary Bifido stack maps directly to the identified signal. No R&D from scratch — we assign from a validated formulation library.
Brand creation
AI-assisted positioning, naming, creative, and packaging. A new brand from brief to launch-ready in weeks, not quarters.
Channel activation
Amazon, TikTok Shop, and DTC simultaneously. Paid, organic, and influencer playbooks pre-built for each consumer archetype.
Scale & compound
Real purchase and reorder data feeds the next brand. Each launch makes the engine smarter and cheaper to operate.
Pipeline: 3 new brands launch-ready · Athletic Performance Nutrition · Muscle Retention Formula · 4 more Bifido SKUs in development
From Daily Support to Clinical Precision
Element Longevity
The lead brand. Multi-strain synbiotic targeting longevity, gut restoration, and systemic inflammation. Clinically dosed, zero-bloat.
Holy Cow!
Once-daily lactose digestion support. Precision prebiotic + Bifido formula. Built for the 50M Americans with dairy sensitivity.
Human Strain
Single-strain purity for the science-informed buyer. B. adolescentis in research-grade concentration. No fillers, no blends.
R3VY
Gut-energy axis optimization for active adults. Bifido + targeted nutrition for metabolic performance and recovery.
Momentum That Compounds
Amazon
PRIMARYSeller Central live. Products indexed and converting. Prime-eligible. Reviews building. The largest supplement discovery platform in North America.
TikTok Shop
GROWTHNative TikTok commerce. Short-form content drives discovery at sub-$15 CAC. Fastest growing supplement channel. Creator-led strategy active.
DTC Storefront
DIRECTShopify live. Full margin capture. Email and SMS retention sequences. Subscription protocols with 25% opt-in rate.
Retail Pilot
EXPANDINGRetail distribution pilot agreements in place. Multi-location rollout planned with brand selection per channel demographics.
Where Personalized Health Is Converging
Our Advantage
- Continuous, biology-informed personalization
- Human-native microbial foundation
- Integrated nutrition across daily → clinical use cases
- Proprietary data and protocol refinement loop
- Designed for action, not just insight

Market Focus with Traction & Trajectory
TAM $10.8B | SAM $3.2B | SOM $160M
Lactose Intolerance / Probiotic Therapeutics
North American consumers; dietary supplements/probiotics segment. Growth: 7% CAGR.
TAM $101B | SAM $20B | SOM $1B
Precision Medicine / Digital Gut-Health Personalization
North America, digital health & microbiome personalization. Growth: 20% CAGR.
TAM $600B | SAM $120B | SOM $1.2B
Functional Foods & Beverages / Gut-Health and Longevity
North American probiotic/functional bevs, bars, powders. Growth: 10% CAGR.

Meet the Team

Haig Newton
CEO

Nick Perez
CMO

Darren Becket
CXO, Product & Education Lead

Dr. Challa
Investor & Advisor

Tim Lambrecht
Investor & Advisor

Dr. Cora
Compliance

Dr. Zorgani
Research

Wes
AMZ Marketing

Adam
Sales Los Angeles

Isher
Lead Engineer

Daniel
Lead Design

Kayla
Sales Denver
Financials Projections & Unit Economics
Unit
Economics
Use of Funds
1 Year Costs

Capital Pathways: Two Ways to Partner with Us
We have two distinct ways to get involved.
1. Equity Path (SAFE Note) OPEN
- $1M raise target
- $350k raised to date (equity)
- 20% discount on next round
- $5M valuation cap
- Supported by key advisors across biotech, wellness, and digital health
2. Strategic Path (Custom Product Partnerships)
- Joint venture or co-develop a custom product/plan within our ecosystem.
- Opportunity to sponsor or enable tailored wellness solutions in the app.
- Designed for multi-location retail, corporate wellness, or investors seeking scalable engagement.
Strategic partners may also provide capital in the form of convertible loans or growth financing, tied to product rollout, packaging, or audience expansion. This enables partners to directly accelerate growth while participating in future upside.

Join the Revolution
We are raising our Series A. Contact us for details.